Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00148915 · ClinicalTrials.gov registry record · Phase 4
A Study To Assess the Quality and Strength of Bone in Women Participants With Osteoporosis Taking Oral Ibandronate Versus Placebo
A Phase 4 study, sponsored by Hoffmann-La Roche.
- Completed
- Registry status
- Phase 4
- Development phase
- 98
- Enrollment target
NCT00148915 is a Phase 4 study that has completed, run by Hoffmann-La Roche. The registered enrollment target is 98 participants.
The verdict
NCT00148915, a Phase 4 study, has completed, sponsored by Hoffmann-La Roche.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 98 participants
- Enrollment target
Study Summary
The purpose of this randomized, double-blind, placebo-controlled study is to estimate the effect of oral ibandronate sodium (Boniva) taken once monthly versus placebo on bone quality and strength at the proximal femur at one year.
Interventions
- DRUG Placebo
- DRUG ibandronate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2005-08 |
| Est. Completion | 2007-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00148915
The ClinicalTrials.gov registry entry for NCT00148915 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hoffmann-La Roche, which has 909 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00148915 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00148915 about?
NCT00148915 is a clinical study titled "A Study To Assess the Quality and Strength of Bone in Women Participants With Osteoporosis Taking Oral Ibandronate Versus Placebo". The purpose of this randomized, double-blind, placebo-controlled study is to estimate the effect of oral ibandronate sodium (Boniva) taken once monthly versus placebo on bone quality and strength at the proximal femur at one year.
What is the current status of trial NCT00148915?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 98 participants. The study started on 2005-08. Estimated completion is 2007-08.
What interventions are being tested in trial NCT00148915?
The interventions under investigation include: Placebo (DRUG), ibandronate (DRUG).
Who is sponsoring clinical trial NCT00148915?
This trial is sponsored by Hoffmann-La Roche, which has 909 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.